Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review

Haiyan Zeng, Lizza E. L. Hendriks, Wouter H. van Geffen, Willem J. A. Witlox, Danielle B. P. Eekers, Dirk K. M. De Ruysscher*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Article number102025
Number of pages17
JournalCancer Treatment Reviews
Volume88
DOIs
Publication statusPublished - Aug 2020

Keywords

  • Lung cancer
  • Prophylactic cranial irradiation
  • Neurocognitive decline
  • Cognition impairment
  • Risk factor
  • QUALITY-OF-LIFE
  • WHOLE-BRAIN RADIOTHERAPY
  • PHASE-III TRIAL
  • RANDOMIZED CONTROLLED-TRIAL
  • RADIATION-THERAPY
  • RTOG 0212
  • COGNITIVE DYSFUNCTION
  • EORTC 22003-08004
  • METASTASES
  • ONCOLOGY

Cite this